跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANGUSTA 25 MICROGRAMOS COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ANGUSTA 25 MICROGRAMOS COMPRIMIDOS
Approved
STANDARD
ANGUSTA 25 MICROGRAMOS COMPRIMIDOS
Norgine B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 15, 2020
Approval ID
d6c9f8c7258d6063
Company
Norgine B.V.
Type
Standard
Approval Details
Approval Id
d6c9f8c7258d6063
Drug Cima Aemps Name
ANGUSTA 25 MICROGRAMOS COMPRIMIDOS
Register Number
85394
Holder Company Name
Norgine B.V.
Marketing Company Name
Norgine De Espana S.L.U.
Holder Company Detail Path
/organization/norgine-b-v
Authorization Date
2020-10-15
Dosage Form
COMPRIMIDO
Dose
25 microgramos
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Norgine B.V.
Company Detail Path
/organization/norgine-b-v
Company Information
Pharmaceutical Company Name
Norgine B.V.
Country Name
Netherlands
City Name
amsterdam,noord-holland,country_nl
Address
Antonio Vivaldistraat 150
Active Ingredients
MISOPROSTOL
0,025 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 15, 2020
Approval ID
d6c9f8c7258d6063
Type
Standard
Back to CIMA-AEMPS Approvals